Edward R. O’Brien - Concepedia

Author

Edward R. O’Brien

Also Known As

E O'Brien, E OBRIEN, E O’Brien, E R O'Brien, E. O'Brien, E. O’Brien, E. R. O'Brien, E.R. O'Brien, Ed O'Brien, Edward O'Brien

235

Publications

Citations

H-Index

126

Concepts

All Affiliations

University of Ottawa Libin Cardiovascular Institute of Alberta University of Washington University of Calgary Ottawa Hospital

About

Edward R. O’Brien is an author at University of Ottawa specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	38	3.6K
2	Public Health	5	5	292
3	Natural Sciences	4	4	112
4	Health Sciences	3	3	713
5	Social Sciences	2	2	91

Edward R. O’Brien

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, The Lancet Oncology 5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials	2017	578
A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction Michel R. Le May, Derek So, Richard Dionne, New England Journal of Medicine	2008	434
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial Jason D. Roberts, George A. Wells, Michel R. Le May, The Lancet ThrombosisFamily MedicineGenetic TestingPoint-of-care Genetic TestingBlood Platelet	2012	389
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Edward R. O’Brien, Charles E. Alpers, Douglas K. Stewart, Circulation Research	1993	364
Detection of Chlamydia pneumoniae TWAR in Human Coronary Atherectomy Tissues Lee Ann Campbell, Edward R. O’Brien, A Cappuccio, The Journal of Infectious Diseases Coronary ArteriesC. PneumoniaePathogenesisChlamydia Pneumoniae TwarDiagnosis	1995	345
Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Edward R. O’Brien, Michael R. Garvin, Douglas K. Stewart, Arteriosclerosis and Thrombosis A Journal of Vascular Biology Vascular DiseaseSclerostinEndothelial CellsImmunologyExtracellular Opn Protein	1994	317
Angiogenesis in human coronary atherosclerotic plaques. Edward R. O’Brien, Michael R. Garvin, R Dev, PubMed	1994	273
Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study) Michel R. Le May, George A. Wells, Marino Labinaz, Journal of the American College of Cardiology Capital Ami StudyThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery Disease	2005	253
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae K L Godzik, Edward R. O’Brien, S K Wang, Journal of Clinical Microbiology VasculitisMicrobial PathogensEndothelial CellsVitro SusceptibilityImmunology	1995	192
Gene Dosage of the Common Variant 9p21 Predicts Severity of Coronary Artery Disease Sonny Dandona, Alexandre F.R. Stewart, Li Chen, Journal of the American College of Cardiology Gene DosageCardiovascular DiseaseMedicineGeneticsGenetic Epidemiology	2010	152

Page 1